Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouA first order of facial cleanser is not really a marketing decision — it is a bet that three numbers will agree: what your channel plan says you can sell, what your factory's fill…
A first order of facial cleanser is not really a marketing decision — it is a bet that three numbers will agree: what your channel plan says you can sell, what your factory’s fill and packaging minimums will allow, and what your registration timeline and shelf life will tolerate. When those three disagree, new GCC skincare brands end up in one of two predictable places: sold out in six weeks with a twelve-week reorder, or holding stock that is quietly aging toward expiry while the launch budget is already spent. This guide turns the forecast into a working document that your manufacturer, your lab, and your distributor can all plan against — including the evidence to request before you confirm a purchase order.
Informational only, not legal or regulatory advice. Registration and labeling requirements differ by GCC market and change over time; confirm with your regulatory affairs partner.
Most new brands forecast top-down: category size, target share, launch support, and a growth curve. That number is then handed to a manufacturer who can only produce in fixed increments — a bulk batch minimum, a filling minimum, and a component minimum that is often higher than both. The forecast and the factory are answering different questions.
Three structural issues make cleanser especially exposed:
Decide the entry market and the entry channel before anything else — a Saudi retail launch, a UAE pharmacy launch, and a marketplace-led launch produce very different first orders. Get a written velocity assumption from the party closest to the shelf, and treat it as an assumption to be tested, not a commitment.
Ask for the numbers in writing: bulk batch minimum, fill minimum, component minimum, decoration minimum, carton minimum, and production lead time from PO to ex-works. Ask separately for the reorder lead time, because that number — not the first order — determines your stockout risk.
Registration or notification lead time sets your earliest realistic on-shelf date, and Arabic labeling review is a dependency, not an afterthought. In the GCC this typically involves market-specific notification (for example, SFDA in Saudi Arabia and the relevant municipal authority in the UAE) plus conformity to Gulf standards. Confirm the exact pathway and dossier requirements for each market with your regulatory team, and confirm whether your channel partners will ask for halal certification before you lock the formula — it is far cheaper to design for it than to retrofit it.
Set a maximum acceptable expiry exposure in units. If shelf life is 30 months and your sell-through window is 9 months, every unit above your 9-month demand estimate is a future write-off, no matter how good the unit price was at the higher volume break.
| Forecast input | Why it moves the first-order number | Evidence to request |
|---|---|---|
| Confirmed doors or listings | Sets the base case; unsigned interest cannot be forecast | Signed listing confirmation, distributor term sheet, or draft PO |
| Velocity assumption | Multiplier on doors; the single largest source of error | Comparable-market sell-through data or category benchmark from the distributor |
| Fill and bulk minimums | Defines the floor below which you cannot order | Written MOQ sheet plus batch size and reorder lead time |
| Component and decoration minimums | Frequently the true constraint, especially on pumps and foamers | Packaging supplier MOQ and lead-time confirmation per component |
| Stability and micro data | Caps how much stock you can safely hold and how long you can sell it | Stability protocol and report (accelerated plus real-time), preservative efficacy challenge test |
| Registration timeline | Sets earliest launch date and therefore the first-order delivery window | Notification or registration certificate and dated timeline per market |
| Claims scope | Each claim adds review time and test cost; some claims change the formula | Claim substantiation file and approved label copy |
Doors × units per door per day × days in the forecast window. Use a range, not a point estimate, and label the low case as your order trigger.
Monthly run-rate × months, adjusted for launch-spike decay. Marketplace demand in month one is heavily driven by paid acquisition and influencer seeding; model month three onward separately.
Map Ramadan, Eid, summer travel, and back-to-school against your launch window. A cleanser launched into peak summer travel in the GCC is launching into a different demand curve than one launched in October.
Add cover for lead-time variability, then subtract anything that will still be on hand at month nine of a thirty-month shelf life. The lower of the two numbers is your real order quantity.
The gap is roughly 1,760 units of excess — around 35% of the batch. That is not automatically a bad decision, but it must be a decision: either reduce the initial door count, negotiate a call-off schedule with two deliveries against one bulk batch, extend the forecast horizon to five to six months with a matching marketing plan, or accept the excess as launch inventory with a documented plan for it (sampling, travel size, gifting, or marketplace bundles). What you should not do is round up without writing down why.
| Symptom | Root cause | Prevention | Evidence to request |
|---|---|---|---|
| Stockout in week 6; reorder takes 12 weeks | Forecast modeled first order but not reorder lead time | Set reorder point at forecast demand covering full lead time plus buffer | Written production and reorder lead times; batch scheduling confirmation |
| 30% of units still unsold at month 9 | Quantity rounded up to a minimum with no sell-through plan | Negotiate call-off deliveries or reduce door count | MOQ sheet with call-off terms; dated shelf-life statement |
| Leaks and pump failures reported in market | Component tested with a surrogate formula or only at ambient temperature | Compatibility and transit simulation with the production formula | Packaging compatibility report, drop/vacuum test, transit simulation results |
| Foam quality inconsistent between batches | Viscosity drift or fill-temperature variation against a fixed actuator | Define viscosity and actuator output specifications before the pilot | Finished-product specification with viscosity range; actuator output data; fill record |
| Launch slips past the retail window | Artwork finalized after submission; ingredient list not reconciled to the formula | Freeze formula and label copy before filing; reconcile INCI line by line | Notification or registration certificate; approved Arabic artwork; INCI-to-formula reconciliation |
| Color or odor differs from the approved sample | No tolerance range in the specification; supplier change without notice | Write color and odor ranges into the spec and hold a signed reference sample | Batch COA against specification; retained sample program |
| “Gentle” or “sensitive-skin” claim questioned | Claim made without a supporting study | Define the claim set first, then commission only the studies that support it | Patch or HRIPT report, claim substantiation file, label copy approval |
| Shipment held at customs or blocked at retailer onboarding | Document pack incomplete or inconsistent across markets | Build the document pack as a deliverable with a named owner | COA, SDS, certificate of free sale, GMP evidence, full registration dossier |
| Phase | Buyer action | Manufacturer action | Evidence output |
|---|---|---|---|
| 1. Brief and market lock (weeks 0–2) | Confirm first market, channel, price band, hero SKU, claim set | Feasibility review, MOQ and lead-time quote | Signed brief, MOQ sheet, indicative timeline |
| 2. Formula and packaging selection (weeks 2–5) | Approve lab samples and component direction | Bench samples, packaging sourcing, compatibility pre-check | Approved formula spec, component drawings, sample sign-off |
| 3. Testing and artwork (weeks 5–12) | Freeze label copy; submit for regulatory review | Start stability, micro, and compatibility testing | Stability protocol, challenge test initiation, artwork files |
| 4. Registration and notification (overlaps 3, typically 4–12 weeks) | Submit dossier per market; track queries | Supply technical file, SDS, GMP evidence | Notification or registration certificate; approved Arabic artwork |
| 5. Pilot or first production (weeks 12–16) | Approve pilot samples against the spec | Bulk manufacture, fill, and pack | Pilot report, batch record, COA, retained samples |
| 6. Documentation handoff and release (weeks 16–18) | Verify the document pack against the purchase order | Compile release documents and shipping paperwork | Complete document pack, release certificate, shipping documents |
Fastest safe path: compress phases 1–2 by arriving with a defined brief and a chosen packaging direction, and run artwork review in parallel with stability rather than after it. Do not compress stability, micro, or regulatory review — those are the items that decide whether you can legally and safely sell.
Standard path: add two to four weeks for a second round of samples and a second artwork cycle. This is usually the lower-risk choice for a brand launching into retail or pharmacy, where a packaging or label defect is visible to every buyer.
Share: first GCC market, launch channel, and target on-shelf date.
Share: hero SKU, size, format (gel / cream / foaming / micellar), and pack type.
Confirm: bulk batch minimum, fill minimum, and reorder lead time in writing.
Confirm: component, decoration, carton, and label minimums per item.
Request: call-off delivery options against a single bulk batch.
Provide: target retail price band and required ex-works cost ceiling.
Attach: reference products and the specific sensory attributes to match.
Approve: fragrance direction, color target, and viscosity expectation.
Lock: full claim list before formula freeze, including Arabic copy.
Request: stability protocol, timepoints, and test conditions.
Request: preservative efficacy challenge test scope and acceptance criteria.
Request: packaging compatibility and transit test plan for the chosen actuator.
Confirm: finished-product specification with pH, viscosity, color, and odor ranges.
Confirm: microbiological release specification per batch.
Review: INCI list reconciliation against the final formula.
Review: Arabic label artwork against the approved claim list.
Confirm: registration pathway, dossier owner, and expected review duration.
Confirm: halal certification requirement with channel partners before formula lock.
Request: COA template, SDS, certificate of free sale, and GMP evidence.
Confirm: shelf-life statement and date-coding format on pack.
Agree: retained sample quantity and storage duration.
Agree: deviation and out-of-spec notification process.
Agree: reorder trigger point in units and weeks of cover.
Lock: first order quantity with a written expiry exposure calculation.
There is no universal number, but the order should be the lower of two figures: your demand forecast plus a defined safety buffer, or the quantity you can sell before month nine of the product’s shelf life. In practice, most first orders are set by packaging minimums rather than by demand, so the negotiation that matters is call-off delivery, not the unit price at a higher volume break.
One. A single size keeps component minimums, artwork review, stability, and compatibility testing to one pass. Add a travel or discovery size once you have real velocity data — it is a better second-order decision than a first-order guess.
Yes, at least at the channel level. Registration pathways, labeling requirements, retail calendars, and velocity benchmarks differ between markets, and a single blended forecast hides the difference. Build the model by market, then consolidate for the factory.
Timelines vary by market and by dossier completeness, and they should be treated as a launch dependency rather than an administrative step. Ask your regulatory partner for a dated timeline per market, and sequence artwork approval before submission so you are not re-filing because the label changed. Do not plan a launch date that assumes approval will arrive early.
In practice, it is usually the label artwork package — Arabic copy, claim wording, and the INCI list not yet reconciled to the final formula. The second most common is an incomplete batch documentation set. Both are preventable by making the document pack a deliverable with a named owner and a delivery date, not something assembled at the end.
If you want a forecast reviewed against real production minimums, or a quote built around a specific market, channel, and pack direction, Request a Quote and include your target markets, SKU list and formats, positioning, packaging direction, and launch window — those five inputs are what turn a general estimate into a schedule you can plan against.